Verastem Oncology
VSTM
C$8.01
Share price
-1.51%
Change (1 day)
64.00%
Change (1 year)
Categories
Verastem Oncology (VSTM) - Net assets
Net assets on the balance sheet as of March 2025 : -C$44.19 Million
According to Verastem Oncology
's latest financial reports the company has -C$44.19 Million in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Verastem Oncology - Net assets on balance sheet (from 2011 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $C$76.09 M | 18.34% |
| 2022-12-31 | $C$64.3 M | -42.37% |
| 2021-12-31 | $C$0.11 B | -24.08% |
| 2020-12-31 | $C$0.14 B | 1468.7% |
| 2019-12-31 | $C$9.36 M | -94.47% |
| 2018-12-31 | $C$0.16 B | 133.47% |
| 2017-12-31 | $C$72.52 M | -25.35% |
| 2016-12-31 | $C$97.15 M | -31.65% |
| 2015-12-31 | $C$0.14 B | 37.99% |
| 2014-12-31 | $C$0.10 B | -17.61% |
| 2013-12-31 | $C$0.12 B | 38.98% |
| 2012-12-31 | $C$89.95 M | 59.71% |
| 2011-12-31 | $C$56.32 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Curis CRIS | -C$9.01 Million | -79.63% | 🇺🇸 USA |
 Pfizer PFE | C$123.48 B | -279,559.19% | 🇺🇸 USA |
 LabCorp LH | C$11.33 B | -25,758.13% | 🇺🇸 USA |
 GlaxoSmithKline GSK | C$24.06 B | -54,568.91% | 🇬🇧 UK |